B
Cannara Biotech Inc. LOVE.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

05/31/2025 02/28/2025 11/30/2024 08/31/2024 05/31/2024
Net Income 27.20% 38.18% -60.11% 183.00% 157.88%
Total Depreciation and Amortization -21.27% 1.17% -12.59% 16.36% 2.57%
Total Amortization of Deferred Charges -- 17.36% 62.42% -- --
Total Other Non-Cash Items 35.20% -11.79% 135.97% -190.77% -128.85%
Change in Net Operating Assets 173.75% -2,709.07% 242.07% -95.84% 602.40%
Cash from Operations 654.88% -142.01% 82.27% -26.69% 54.30%
Capital Expenditure -52.93% -15.98% -145.74% 84.08% -171.52%
Sale of Property, Plant, and Equipment -- -- -73.81% -99.45% --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -23.06% 71.67% -11.48% 16.55% -13.68%
Cash from Investing -55.68% -14.38% -167.83% 54.02% 13.42%
Total Debt Issued -- -- -- -100.00% 120.00%
Total Debt Repaid -926.12% 72.92% -4.75% 81.00% -437.69%
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 31.82% -19.15% 9.95% -333.50% 85.56%
Cash from Financing -95.09% -18.68% 36.33% -51.47% 13.75%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 282.85% -237.45% 213.54% -50.71% 368.44%